OrganiGram (OGI) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
23 Aug, 2026Executive summary
Achieved record quarterly net revenue of $105.8M (CAD 105.8 million), up 49% year-over-year, driven by the consolidation of Sanity Group and strong Canadian operations.
Adjusted EBITDA reached $13.4M, a 136% increase year-over-year, with margin expansion due to operational efficiencies and international growth.
Sanity Group contributed approximately €25 million (C$40 million) in revenue since acquisition, supporting international expansion and establishing leadership in Germany.
International revenue now represents over one-third of total revenue, marking a significant shift in business profile.
Leadership transition announced with the departure of a key executive after nine years.
Financial highlights
Net revenue for Q3 was $105.8M (CAD 105.8 million), up 49% year-over-year from $70.8M.
Adjusted gross margin reached 37%, up from 34% year-over-year and 600 basis points sequentially.
Adjusted EBITDA rose to $13.4M from $5.7M year-over-year.
Net income was $105.5M, compared to a loss of $6.3M last year, mainly due to fair value gains on financial assets.
Free cash flow was an outflow of $3.9M, reflecting increased working capital needs.
Outlook and guidance
On track for net revenue to exceed $350M for fiscal 2026, with adjusted gross margin and adjusted EBITDA expected to surpass fiscal 2025 levels.
Sanity Group expected to contribute an average revenue run rate of €25M per quarter, increasing consolidated profitability and international sales volumes.
Modestly negative free cash flow anticipated for the full year, but positive free cash flow expected in Q4.
Latest events from OrganiGram
- Q2 revenue fell 9%, but European expansion and Sanity deal support FY26 revenue above $350M.OGI
Q2 2026 - Q1 net revenue grew 49% with strong margins, profitability, and Canadian market leadership.OGI
Q1 2026 - Record revenue, strong global expansion, and innovation drive leadership in cannabis.OGI
Investor Presentation - Record revenue, margin gains, and global expansion drive growth, with U.S. regulatory risks ahead.OGI
Q4 2025 - Motif deal, revenue gains, and global expansion make the company Canada's cannabis market leader.OGI
Q4 2024 - Returned to profitability with 25% revenue growth and expanded global footprint.OGI
Q3 2024 - Market leader drives growth through innovation, efficiency, and global expansion.OGI
Status Update - Record revenue, margin gains, and global expansion drive strong Q2 performance.OGI
Q2 2025 - Net revenue up 17% and Motif acquisition drive market leadership and global expansion.OGI
Q1 2025